Cargando…
Apolipoprotein A1 is associated with osteocalcin and bone mineral density rather than high-density lipoprotein cholesterol in Chinese postmenopausal women with type 2 diabetes mellitus
OBJECTIVE: Disturbances in high-density lipoprotein cholesterol (HDL-c) metabolic pathways can affect bone metabolism, which may rely on the particle function of apolipoprotein rather than HDL-c levels. This study aimed to evaluate the correlation of serum HDL-c and apolipoprotein A1 (APOA1) with bo...
Autores principales: | Wang, Wei, Chen, Zhe Yuan, Lv, Fen Yan, Tu, Mei, Guo, Xiu Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308019/ https://www.ncbi.nlm.nih.gov/pubmed/37396919 http://dx.doi.org/10.3389/fmed.2023.1182866 |
Ejemplares similares
-
The Changes of CTX, DPD, Osteocalcin, and Bone Mineral Density During the Postmenopausal Period
por: Park, Seok Gyo, et al.
Publicado: (2018) -
Association between undercarboxylated osteocalcin, bone mineral density, and metabolic parameters in postmenopausal women
por: Zanatta, Leila C. B., et al.
Publicado: (2018) -
Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016) -
Apolipoprotein E and undercaboxylated osteocalcin are associated with bone fragility but not with bone mineral density in osteoarthritis patients
por: Rodrigues, Ana, et al.
Publicado: (2011) -
Evaluation of Bone Mineral Density, Serum Osteocalcin, and Osteopontin Levels in Postmenopausal Women with Type 2 Diabetes Mellitus, with/without Osteoporosis
por: Roomi, Ali B., et al.
Publicado: (2022)